• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经前女性和年轻女性的子宫内膜癌:危险因素和结局。

Endometrial Cancer in Pre-Menopausal Women and Younger: Risk Factors and Outcome.

机构信息

Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Cheras, Kuala Lumpur 5600, Malaysia.

Department of Pathology, Hospital Melaka, Jalan Mufti Haji Khalil, Melaka 75400, Malaysia.

出版信息

Int J Environ Res Public Health. 2022 Jul 25;19(15):9059. doi: 10.3390/ijerph19159059.

DOI:10.3390/ijerph19159059
PMID:35897440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330568/
Abstract

Endometrial cancer is the sixth most common malignancy in women, and it is known to be a disease among postmenopausal women, but there is rising in the number of endometrial cancers among premenopausal women. This study aims to determine the clinical characteristic, risk factors, outcomes, and survival in pre and postmenopausal women with endometrial cancer in Malaysia. A retrospective study was conducted in Hospital Melaka that involved all women who were diagnosed with endometrial cancer in Hospital Melaka from January 2002 until July 2020. All subjects' histopathological examination result was confirmed, and their clinical data were extracted and transferred into a standardized data checklist and analysed. A total number of 392 cases was obtained from the Annual Cancer Registry Hospital Melaka. However, only 281 cases were studied, including 44.8% premenopausal and 55.2% postmenopausal women. In the premenopausal group, there were higher incidence of obesity (30.8 + 8.6 vs. 28.9 + 7.1), younger age at menarche (12.7 + 1.5 vs. 13.3 + 1.6), lesser parity (1.47 vs. 3.26), and a higher number of nulliparous women (46.8% vs. 19.4%) as compared to postmenopausal group. The premenopausal group tends to be presented with a well-differentiated grading of tumour (52.4%) and a higher incidence of having concomitant endometrial hyperplasia (41.3%). The mean survival among the premenopausal group (200.3 + 7.9 months) is higher compared to postmenopausal group (153.9 + 6.5 months). These findings correlate with good survival and prognosis among the premenopausal group compared to the postmenopausal group.

摘要

子宫内膜癌是女性中第六种最常见的恶性肿瘤,已知是绝经后妇女的一种疾病,但绝经前妇女的子宫内膜癌数量正在增加。本研究旨在确定马来西亚绝经前和绝经后妇女子宫内膜癌的临床特征、危险因素、结局和生存率。这项回顾性研究在马六甲医院进行,涉及所有在马六甲医院被诊断为子宫内膜癌的女性,时间为 2002 年 1 月至 2020 年 7 月。所有患者的组织病理学检查结果均得到证实,并提取和转移其临床数据到标准化数据检查表中进行分析。从马六甲年度癌症登记处获得了 392 例病例。然而,仅对 281 例进行了研究,包括 44.8%的绝经前和 55.2%的绝经后妇女。在绝经前组中,肥胖发生率更高(30.8+8.6 比 28.9+7.1),初潮年龄更小(12.7+1.5 比 13.3+1.6),生育次数更少(1.47 比 3.26),未生育的女性更多(46.8%比 19.4%)。与绝经后组相比,绝经前组的肿瘤分级分化程度更高(52.4%),同时患有子宫内膜增生的发生率更高(41.3%)。绝经前组的平均生存时间(200.3+7.9 个月)高于绝经后组(153.9+6.5 个月)。这些发现与绝经前组比绝经后组有更好的生存和预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7c6/9330568/2f20dec5fbc8/ijerph-19-09059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7c6/9330568/e725a263fbdd/ijerph-19-09059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7c6/9330568/2f20dec5fbc8/ijerph-19-09059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7c6/9330568/e725a263fbdd/ijerph-19-09059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7c6/9330568/2f20dec5fbc8/ijerph-19-09059-g002.jpg

相似文献

1
Endometrial Cancer in Pre-Menopausal Women and Younger: Risk Factors and Outcome.绝经前女性和年轻女性的子宫内膜癌:危险因素和结局。
Int J Environ Res Public Health. 2022 Jul 25;19(15):9059. doi: 10.3390/ijerph19159059.
2
Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.体重指数在决定是否进行子宫内膜活检方面比年龄更具影响力:有症状的绝经前女性队列研究
Am J Obstet Gynecol. 2016 Nov;215(5):598.e1-598.e8. doi: 10.1016/j.ajog.2016.06.006. Epub 2016 Jun 8.
3
Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.根据临床病理特征,绝经前和绝经后妇女的子宫内膜息肉的恶性肿瘤风险。
Menopause. 2011 Dec;18(12):1278-82. doi: 10.1097/gme.0b013e31821e23a1.
4
Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.有症状的他莫昔芬治疗组与未治疗的绝经前和绝经后乳腺癌患者子宫内膜变化的比较。
Gynecol Oncol. 1997 Aug;66(2):233-7. doi: 10.1006/gyno.1997.4739.
5
Do obesity and age effect the clinicopathological features and survival outcomes in premenopausal women with endometrial cancer?肥胖和年龄是否会影响绝经前子宫内膜癌女性的临床病理特征和生存结果?
Eur J Gynaecol Oncol. 2016;37(3):320-6.
6
Outcomes in women age 40 years and older with cytologically benign endometrial cells.40 岁及以上细胞学良性子宫内膜细胞女性的结局。
Am J Obstet Gynecol. 2012 Nov;207(5):379.e1-6. doi: 10.1016/j.ajog.2012.08.018. Epub 2012 Aug 16.
7
Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?肥胖无症状绝经前后乳腺癌患者的子宫内膜息肉:有必要筛查吗?
Gynecol Oncol. 2014 Apr;133(1):56-62. doi: 10.1016/j.ygyno.2013.12.029.
8
Risk factors for young premenopausal women with endometrial cancer.年轻绝经前子宫内膜癌女性的危险因素。
Obstet Gynecol. 2005 Mar;105(3):575-80. doi: 10.1097/01.AOG.0000154151.14516.f7.
9
Comparison of the clinicopathological characteristics of premenopausal and postmenopausal endometrial carcinomas: analysis of endocrinologically evaluated cases.绝经前与绝经后子宫内膜癌临床病理特征比较:内分泌评估病例分析
Jpn J Clin Oncol. 1996 Jun;26(3):152-6. doi: 10.1093/oxfordjournals.jjco.a023199.
10
Case-control study of endogenous steroid hormones and endometrial cancer.内源性甾体激素与子宫内膜癌的病例对照研究。
J Natl Cancer Inst. 1996 Aug 21;88(16):1127-35. doi: 10.1093/jnci/88.16.1127.

引用本文的文献

1
Young Women With Endometrial Cancer: A Portuguese Perspective.患有子宫内膜癌的年轻女性:葡萄牙视角。
Cancer Diagn Progn. 2025 Sep 1;5(5):606-613. doi: 10.21873/cdp.10475. eCollection 2025 Sep-Oct.
2
Potential role of Fanconi anemia pathway in the pathogenesis of endometrial cancer (Review).范可尼贫血通路在子宫内膜癌发病机制中的潜在作用(综述)
Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13660. Epub 2025 Aug 24.
3
Enhancing the therapeutic potential of FDA-approved ifosfamide and 5-fluorouracil through rational chemical modifications for endometrial cancer treatment.

本文引用的文献

1
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives.子宫内膜癌辅助治疗的优化:新标准与新视角
Biology (Basel). 2021 Aug 30;10(9):845. doi: 10.3390/biology10090845.
2
Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments.子宫内膜增生症患者的子宫内膜癌风险因素:对临床治疗的启示。
BMC Womens Health. 2021 Aug 25;21(1):312. doi: 10.1186/s12905-021-01452-9.
3
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
通过合理的化学修饰提高美国食品药品监督管理局批准的异环磷酰胺和5-氟尿嘧啶治疗子宫内膜癌的潜力。
Med Oncol. 2025 Jun 25;42(8):281. doi: 10.1007/s12032-025-02821-2.
4
Comparing survival outcomes between surgical and non-surgical treatments in patients with early-onset endometrial cancer and developing a nomogram to predict survival: a study based on Eastern and Western data sets.比较早期子宫内膜癌患者手术和非手术治疗的生存结局并建立预测生存的列线图:一项基于东西方数据集的研究
World J Surg Oncol. 2025 May 11;23(1):184. doi: 10.1186/s12957-025-03825-y.
5
MFAP5 inhibits the malignant progression of endometrial cancer cells .MFAP5抑制子宫内膜癌细胞的恶性进展。
Open Life Sci. 2024 Dec 31;19(1):20220990. doi: 10.1515/biol-2022-0990. eCollection 2024.
6
The Role of Endometrial Sampling before Hysterectomy in Premenopausal Women with Abnormal Uterine Bleeding.子宫切除术前行子宫内膜取样在绝经前异常子宫出血女性中的作用
J Clin Med. 2024 Jun 25;13(13):3709. doi: 10.3390/jcm13133709.
7
Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion.左炔诺孕酮宫内节育系统治疗不典型增生和早期子宫内膜癌的长期随访结果显示,复发特征为免疫衰竭。
Clin Cancer Res. 2024 Nov 15;30(22):5073-5082. doi: 10.1158/1078-0432.CCR-24-0362.
8
Diagnostic dilemma in female genital tract tuberculosis: A case report.女性生殖道结核的诊断困境:一例报告
Radiol Case Rep. 2024 Jun 2;19(8):3439-3442. doi: 10.1016/j.radcr.2024.04.093. eCollection 2024 Aug.
9
Endometrial Cancer in Reproductive-Aged Females: Etiology and Pathogenesis.育龄女性子宫内膜癌:病因与发病机制
Biomedicines. 2024 Apr 17;12(4):886. doi: 10.3390/biomedicines12040886.
10
Evaluating the Prognostic Factors and Survival Rates of Endometrial Cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.评估泰国东北部一家三级转诊医院子宫内膜癌患者的预后因素和生存率。
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):671-679. doi: 10.31557/APJCP.2024.25.2.671.
分子分类时代的子宫内膜癌辅助治疗:放疗、放化疗和新的治疗靶点。
Int J Gynecol Cancer. 2021 Apr;31(4):594-604. doi: 10.1136/ijgc-2020-001822. Epub 2020 Oct 20.
4
Age at Menopause and Risk of Developing Endometrial Cancer: A Meta-Analysis.绝经年龄与子宫内膜癌发病风险的关系:Meta 分析。
Biomed Res Int. 2019 May 29;2019:8584130. doi: 10.1155/2019/8584130. eCollection 2019.
5
Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes.1型和2型子宫内膜癌的十年比较研究:危险因素与结局
Gynecol Obstet Invest. 2019;84(3):290-297. doi: 10.1159/000493132. Epub 2019 Jan 2.
6
Analysis of endometrial carcinoma in young women at a high-volume cancer center.高发癌症中心的年轻女性子宫内膜癌分析。
Int J Surg. 2017 Aug;44:185-190. doi: 10.1016/j.ijsu.2017.06.083. Epub 2017 Jun 30.
7
Median Survival Time of Endometrial Cancer Patients with Lymphovascular Invasion at the Hospital Universiti Sains Malaysia.马来西亚理科大学附属医院伴有淋巴管浸润的子宫内膜癌患者的中位生存时间
Malays J Med Sci. 2016 Nov;23(6):44-51. doi: 10.21315/mjms2016.23.6.5. Epub 2016 Dec 7.
8
Risk Factors for Endometrial Cancer: Results from a Hospital-Based Case-Control Study.子宫内膜癌的危险因素:一项基于医院的病例对照研究结果
Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4791-4796. doi: 10.22034/apjcp.2016.17.10.4791.
9
Premenopausal abnormal uterine bleeding and risk of endometrial cancer.绝经前异常子宫出血与子宫内膜癌风险。
BJOG. 2017 Feb;124(3):404-411. doi: 10.1111/1471-0528.14385. Epub 2016 Oct 20.
10
Endometrial Cancer in Hospital Universiti Sains Malaysia.马来西亚理科大学医院的子宫内膜癌
Asian Pac J Cancer Prev. 2016;17(6):2867-70.